Metabolic profiles of 20( S )‐protopanaxadiol in rats after oral administration using ultra‐performance liquid chromatography/quadrupole time‐of‐flight tandem mass spectrometry
- 7 February 2014
- journal article
- research article
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 28 (6) , 595-604
Abstract
RATIONALE: 20( S )‐Protopanaxadiol (PPD), a dammarane‐type triterpenoid sapogenin, acts as the pharmacophore of ginsenosides which are considered as the principal bioactive components in Chinese ginseng. To fully understand the mechanism of action of PPD, it is important to study its metabolic profiles in vivo . METHODS: Plasma, urine, fece and bile were collected after administration of PPD formulated in 0.5% aqueous Tween‐80 to rats (150 mg/kg). Samples were analyzed by using a sensitive and reliable method based on ultra‐performance liquid chromatography/quadrupole time‐of‐flight tandem mass spectrometry (UPLC/Q‐TOF‐MS/MS) in both positive and negative ion mode. The chemical structures of metabolites were elucidated by comparing the retention time, accurate molecular mass, and fragmentation patterns of analytes with those of PPD. RESULTS: In total 29 metabolites, including 10 new metabolites (M20–M29), were tentatively identified and characterized. Among them, two metabolites (M3 and M4) were unambiguously identified by matching their retention times and fragmentation patterns with their standards. Principal metabolites, namely, 20, 24‐oxide metabolites (M3 and M4), 26/27‐carboxylic acid derivatives (M22 and M23) and a glucuronidated product (M28), were found in the rat plasma. CONCLUSIONS: The results showed that phase I metabolites are monooxygenation, dioxygenation and oxidative dehydrogenation metabolites, and phase II metabolic pathways were demonstrated to be cysteine conjugation and glucuronidation. The newly identified metabolites are useful to understand the mechanism of elimination of PPD and, in turn, its effectiveness and toxicity. Copyright © 2014 John Wiley & Sons, Ltd.Keywords
Funding Information
- National Natural Science Foundation of China (U1032604)
- China Postdoctoral Science Foundation (2011 M500806)
- Program for Changjiang Scholars and Innovative Research Team in University (IRT1071)
This publication has 22 references indexed in Scilit:
- Biotransformation of ginsenoside Rd in the ginseng extraction residue by fermentation with lingzhi (Ganoderma lucidum)Food Chemistry, 2013
- Metabolite profiling of ginsenoside Re in rat urine and faeces after oral administrationFood Chemistry, 2013
- Determination of ginsenosides Rb1, Rb2, and Rb3 in rat plasma by a rapid and sensitive liquid chromatography tandem mass spectrometry method: Application in a pharmacokinetic studyJournal of Pharmaceutical and Biomedical Analysis, 2012
- Isolation and analysis of ginseng: advances and challengesNatural Product Reports, 2011
- American ginseng: Potential structure–function relationship in cancer chemopreventionBiochemical Pharmacology, 2010
- Microsomal Cytochrome P450-Mediated Metabolism of Protopanaxatriol Ginsenosides: Metabolite Profile, Reaction Phenotyping, and Structure-Metabolism RelationshipDrug Metabolism and Disposition, 2010
- Absorption and Disposition of Ginsenosides after Oral Administration of Panax notoginseng Extract to RatsDrug Metabolism and Disposition, 2009
- Detection of Adulteration of Notoginseng Root Extract with Other Panax Species by Quantitative HPLC Coupled with PCAJournal of Agricultural and Food Chemistry, 2009
- Potential Role of Ginseng in the Treatment of Colorectal CancerThe American Journal of Chinese Medicine, 2008
- Simultaneous rapid quantification of ginsenoside Rg1 and its secondary glycoside Rh1 and aglycone protopanaxatriol in rat plasma by liquid chromatography–mass spectrometry after solid-phase extractionJournal of Pharmaceutical and Biomedical Analysis, 2005